Last 167.00
Change Today +3.00 / 1.83%
Volume 297.3K
INAF On Other Exchanges
Symbol
Exchange
Indonesia
As of 5:00 AM 10/24/14 All times are local (Market data is delayed by at least 15 minutes).

indofarma tbk pt (INAF) Snapshot

Open
$167.00
Previous Close
$164.00
Day High
$169.00
Day Low
$164.00
52 Week High
03/27/14 - $202.00
52 Week Low
01/9/14 - $151.00
Market Cap
517.6B
Average Volume 10 Days
302.6K
EPS TTM
$-30.92
Shares Outstanding
3.1B
EX-Date
05/3/13
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for INDOFARMA TBK PT (INAF)

Related News

No related news articles were found.

indofarma tbk pt (INAF) Related Businessweek News

No Related Businessweek News Found

indofarma tbk pt (INAF) Details

PT Indofarma (Persero) Tbk develops, produces, and sells generic drugs, over the counter, and branded generic drugs primarily in Indonesia. It also trades in and distributes drugs, medical devices, diagnostic products, and hospital furniture. The company was founded in 1918 and is headquartered in Bekasi, Indonesia.

1,858 Employees
Last Reported Date: 07/23/14
Founded in 1918

indofarma tbk pt (INAF) Top Compensated Officers

President Director
Total Annual Compensation: $581.6M
Finance Director and Director
Total Annual Compensation: $581.6M
Operation & Development Director and Director
Total Annual Compensation: $581.6M
Production Director and Director
Total Annual Compensation: $581.6M
Compensation as of Fiscal Year 2012.

indofarma tbk pt (INAF) Key Developments

PT Indofarma Announces Executive Changes

PT Indofarma announced that Elfiano Rizaldi, who previously served as research and marketing director, was approved to take over as president director from Djakfarudin Junus, whose tenure was originally due to end in 2014. The change of president director had been recommended by the majority shareholder — the government — which now holds an 81% stake in the company. Supriyantoro will be leaving his position on the board of commissioners at Indofarma as he was appointed at the AGM as the new president commissioner of KAEF. He will be succeeded by Akmal Taher. Indofarma, meanwhile, will receive two new commissioners: Rina Moreta and Fajar Rahmat Zulkarnaen.

Kalbe Farma And Indofarma Persero Mulls Acquisitions

Company officials of PT Kalbe Farma Tbk and Pt Indofarma Persero Tbk said that they are planning to make acquisitions in 2013 to develop their businesses. Vidjongtius, Director of Kalbe Farma, said, "We will strengthen our business portfolio by exploring the possibilities of merger and acquisition." Kalbe Farma has set aside IDR 200 billion for acquisition. Vidjongtius did not mention the names of the potential targets that Kalbe Farma wants to acquire in 2013.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INAF:IJ 167.00 +3.00

INAF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for INAF.
View Industry Companies
 

Industry Analysis

INAF

Industry Average

Valuation INAF Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.4x
Price/Book 0.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INDOFARMA TBK PT, please visit www.indofarma.co.id. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.